Cargando...
In vitro anti-Toxoplasma gondii efficacy of synthesised benzyltriazole derivatives
Toxoplasma gondii, an obligate intracellular parasite, is the aetiological agent of toxoplasmosis, a disease that affects approximately 25% – 30% of the world’s population. At present, no safe and effective vaccine exists for the prevention of toxoplasmosis. Current treatment options for toxoplasmos...
Gardado en:
| Publicado en: | Onderstepoort J Vet Res |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
AOSIS
2021
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8252180/ https://ncbi.nlm.nih.gov/pubmed/34212734 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4102/ojvr.v88i1.1898 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|